These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 38932359)

  • 21. Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.
    Cui H; Gao H; Cui X; Zhao Y; Shi X; Li Q; Yan S; Gao M; Wang M; Liu C; Wang Y
    PLoS One; 2013; 8(1):e53340. PubMed ID: 23301062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional Analyses of Innate and Acquired Immune Patterning Elicited by Marek's Disease Virus Vaccine Strains: Turkey Herpesvirus (HVT), Marek's Disease Virus 2 (strain SB1), and Bivalent Vaccines (HVT/SB1 and HVT-LT/SB1).
    Neerukonda SN; Katneni UK; Bhandari N; Parcells MS
    Avian Dis; 2019 Dec; 63(4):670-680. PubMed ID: 31865682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.
    Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M
    Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
    Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
    Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newcastle disease virus-attenuated vaccine co-contaminated with fowl adenovirus and chicken infectious anemia virus results in inclusion body hepatitis-hydropericardium syndrome in poultry.
    Su Q; Li Y; Meng F; Cui Z; Chang S; Zhao P
    Vet Microbiol; 2018 May; 218():52-59. PubMed ID: 29685221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chicken infectious anemia virus helps fowl adenovirus break the protection of maternal antibody and cause inclusion body hepatitis-hydropericardium syndrome in layers after using co-contaminated Newcastle disease virus-attenuated vaccine.
    Su Q; Meng F; Li Y; Zhang Y; Zhang Z; Cui Z; Chang S; Zhao P
    Poult Sci; 2019 Feb; 98(2):621-628. PubMed ID: 30358862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Sadigh Y; Powers C; Spiro S; Pedrera M; Broadbent A; Nair V
    NPJ Vaccines; 2018; 3():21. PubMed ID: 29872549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marek's disease vaccines: Current status, and strategies for improvement and development of vector vaccines.
    Reddy SM; Izumiya Y; Lupiani B
    Vet Microbiol; 2017 Jul; 206():113-120. PubMed ID: 28038868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine.
    Lambeth LS; Zhao Y; Smith LP; Kgosana L; Nair V
    Vaccine; 2009 Jan; 27(2):298-306. PubMed ID: 18977264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular-based monitoring of live vaccines in dust samples from experimental and commercial chicken flocks and its potential use as a screening test.
    Assen AM; Yegoraw AA; Walkden-Brown SW; Gerber PF
    Res Vet Sci; 2022 Mar; 143():50-57. PubMed ID: 34973539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus.
    Liu S; Sun W; Chu J; Huang X; Wu Z; Yan M; Zhang Q; Zhao P; Igietseme JU; Black CM; He C; Li Y
    PLoS One; 2015; 10(4):e0124992. PubMed ID: 25893439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
    Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
    J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL
    Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant herpesvirus of turkeys as a vector-based vaccine against highly pathogenic H7N1 avian influenza and Marek's disease.
    Li Y; Reddy K; Reid SM; Cox WJ; Brown IH; Britton P; Nair V; Iqbal M
    Vaccine; 2011 Oct; 29(46):8257-66. PubMed ID: 21907750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
    Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
    Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
    Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
    Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.